Pancreatic cancer is a rare disease; however, its initially inconspicuous symptoms and aggressive nature make it one of the deadliest forms of cancer.
Jan 15, 2026
0
0
Each year, more than two million people die from advanced chronic liver disease (ACLD). Previous research has linked gut microbiome disruptions to this condition and suggested that bacteria typically found in the mouth may ...
Jan 15, 2026
0
63
Although she's not an entomologist, Maggie Stanislawski, Ph.D., spends hours a day studying bugs. The assistant professor of biomedical informatics specializes in the gut microbiome, an environment swimming with trillions ...
Jan 15, 2026
0
1
Pancreatic ductal adenocarcinoma (PDAC) is the most common type of pancreatic cancer and begins in the cells lining the pancreatic duct. Accounting for more than 90% of all pancreatic cancers, PDAC is extremely difficult ...
Jan 15, 2026
0
0
A research team at Tohoku University, in collaboration with Denka Company Limited and U-A Corporation, has developed a high-fidelity "dry" simulator for endoscopic submucosal dissection (ESD). ESD is a minimally invasive ...
Jan 14, 2026
0
0
Children born to mothers who consume a high-fat, high-sugar diet during pregnancy and breastfeeding face a higher risk of developing fatty liver disease later in life.
Jan 14, 2026
0
38
According to a recent study by researchers at the University of the Basque Country (EHU), raising social awareness is essential to improving the well-being of celiac individuals.
Jan 14, 2026
0
0
Pregnant individuals with inflammatory bowel disease (IBD) have higher levels of pro-inflammatory immune molecules, known as cytokines, in their vaginal mucosa than their healthy counterparts, according to a new study by ...
Jan 14, 2026
0
0
Antibiotics (ABs) are among the most used pharmaceutical drugs worldwide, as they are currently the most effective medicines for the treatment of bacterial infections. An excessive use of these drugs, however, can damage ...
Researchers at McMaster University are leading preclinical studies into a novel drug candidate developed by Espervita Therapeutics that has the potential to prevent and reverse liver fibrosis—a dangerous, disease-induced ...
Jan 13, 2026
0
23
